bioMerieux

BIM.PA Large Cap

Healthcare · Diagnostics & Research

Updated: Apr 5, 2026, 17:43 UTC

€93.65

+1.02% today

52W: €87.60 – €128.30

52W Low: €87.60 Position: 14.9% 52W High: €128.30

🔗 Compare Brokers

Key Metrics

P/E Ratio

28.04x

Price-to-Earnings

Forward P/E

17.49x

Forward Price/Earnings

P/S Ratio

2.71x

Price-to-Sales

EV/EBITDA

9.69x

Enterprise Value/EBITDA

Div. Yield

105%

Annual dividend yield

Market Cap

$11B

Market Capitalization

Revenue Growth

-2.5%

YoY Revenue Growth

Profit Margin

9.77%

Net profit margin

ROE

9.54%

Return on Equity

Beta

0.67

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

141,507

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

13 analysts

Avg. Price Target

€116.04

+23.91% upside

Target Range

€100.00 – €138.00

About the Company

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture me

Sector: Healthcare Industry: Diagnostics & Research Country: France Employees: 14,562 Exchange: PAR